RankingsPricing
  1. US-listed companies
  2. Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.KYMR

Market cap
$2.7B
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data